AstraZeneca Pharma to launch breast cancer drug, shares jump

Source: Money Control AstraZeneca Pharma shares gained 6 percent intraday on December 21 after the pharma company said it will launch Enhertu, a breast cancer drug, in January 2024 in India. “Enhertu is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received a prior anti-HER2-based regimen,” said […]
US FDA declines to approve Zealand Pharma’s drug for low blood sugar in Infants

The company is seeking regulatory approval for the use of the drug in patients aged seven days or older with CHI, a genetic disorder in which the insulin cells of the pancreas secrete too much insulin. New Zealand: The U.S. Food and Drug Administration (FDA) declined to approve Zealand Pharma‘s drug for the prevention and treatment of low […]
Maiden Pharma denies tampering with tests in probe of cough syrup deaths of children in Gambia

Source: Reuters India’s Maiden Pharmaceuticals, whose cough syrups have been linked to the deaths of children in Gambia, on Saturday denied it had tampered with test samples or bribed officials to do so, as alleged in a complaint under investigation by local health officials. An investigator with the state of Haryana’s Food and Drug Administration […]
Pharma Ratna Universe 2023

Delhi: 17th Dec 2023 The Pharma Ratna Universe 2023 was held at Crown Plaza Hotel Rohini Delhi. The event hosted more than 350 members from across the Global Pharma Industry. These members included Pharma Leaders, Mentors, Regulatory, Manufacturers, Academicians, Drug Safety, Exporters & Importers. The event had so many takeaways for all the members who […]
Newest COVID Variant ‘JN.1’ Sparks Worries Among Scientists

Source: TimesNow New Delhi: Scientists are worried about a new COVID-19 variant that has the potential to evade vaccine immunity. The new SARS-CoV-2 variant JN.1 was initially identified in Luxembourg on August 25, 2023. Thereafter, it was also found in England, Iceland, France, and the United States. The extreme divergence of the variant from other […]
Regaining lost ground: It’s time for a future-oriented pharmaceutical policy

Source: Politico The importance of pharmaceutical innovation in Europe cannot be underestimated. The pharma industry is one of Europe’s top-performing high-technology sectors. It contributes around €175B to the EU’s trade balance – a tenfold rise over the last two decades. Despite what seems like encouraging progress, the more recent trends in Europe should be setting […]
AstraZeneca to pay $425 million to settle Nexium, Prilosec litigation in US

Source: Financial Express The agreements effectively resolve all pending claims filed against the company for failing to warn patients about the risk of contracting chronic kidney disease and related issues Pharma major AstraZeneca on Tuesday said it will pay $425 million to settle product liability litigations against prescription-only acid-reflux medicine Nexium and heartburn drug Prilosec in the […]
IQuest Enterprises to acquire active pharma ingredient business of Viatris

Source: Business Standard The investment firm has entered into a definitive agreement to acquire the API operations of global pharmaceutical major Viatris in India, IQuest Enterprises said in a statement on Monday Multi-sector investment firm IQuest Enterprises will acquire the active pharmaceutical ingredients (API) business of Viatris in India for an undisclosed amount. The investment […]
US FDA to step up unannounced inspections on Indian pharma plants

Source: Moneycontrol India will be a dominant part of planning the resilience of supply chains, he added The US drug regulator has declared that there will be more unannounced inspections at the pharmaceutical plants in India. “A mixture of announced and unannounced inspections is important, and you will see more unannounced (inspections),” said United States […]
Cough syrup deaths overseas prompts US crackdown on toxic testing

Source: medicaldialogues The U.S. FDA is cracking down on lax testing practices by dozens of makers of healthcare products following hundreds of deaths overseas from contaminated cough syrups, a Reuters review of regulatory alerts found. The Food and Drug Administration has reprimanded at least 28 companies this year, saying they failed to prove sufficient testing […]